article thumbnail

Survey: Chronic Hand Eczema Affects Patients’ Emotional, Social and Occupational Well-Being

The Dermatology Digest

dermatology providers agree that moderate-to-severe chronic hand eczema (CHE) has a strong impact on patients work and home life, according to the second phase of the survey sponsored by LEO Pharma Inc. Delgocitinib cream (Leo Pharma, Anzupgo), a pan-Janus kinase (JAK)-inhibitor, is in clinical trials. Ninety-five percent of U.S.

Eczema 36
article thumbnail

Investigating the Use of Topical Ruxolitinib in Chronic Hand Eczema

The Dermatology Digest

Significantly more patients who applied ruxolitinib cream 1.5% (Opzelura, Incyte) twice daily achieved Investigator’s Global Assessment-Chronic Hand Eczema (IGA-CHE) treatment success at Week 16 when compared to patients who received vehicle.

Eczema 36
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Eczema & Steroids: Balancing Clear Skin Benefits with Potential Health Risks (2025)

Aesthetics Advisor

Kate learned about topical steroid withdrawal when her son Alex stopped growing, and she took him off his eczema cream. Alexs eczema, also known as atopic dermatitis, began in infancy with small, itchy patches on his wrists and handsa condition Kate, a seasoned nurse, was familiar with. After six months, his eczema was completely gone.

Eczema 36
article thumbnail

Survey Snapshot: Chronic Hand Eczema's Clinical Burden, Treatment Gaps, and Patient Impact Revealed

Dermatology Times

We review survey data revealing diagnostic confusion, treatment gaps, and the emotional, social, and occupational toll of moderate to severe chronic hand eczema.

Eczema 31
article thumbnail

Low Levels of Protein-bound Ceramides May Predict Infants’ Risk for Developing Eczema

The Dermatology Digest

Lower levels of certain lipids in an infants skin may predict risk for developing eczema down the road, according to a new study. The researchers followed children to see who developed eczema and who did not by age one. The researchers followed children to see who developed eczema and who did not by age one.

Eczema 36
article thumbnail

Conference Recap: 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema

Dermatology Times

Catch up on all clinical pearls from the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference in Chicago, Illinois.

Eczema 73
article thumbnail

Alexander Egeberg, MD, PhD, Shares Key Findings on Chronic Hand Eczema and Atopic Dermatitis

Dermatology Times

Egeberg discusses promising new treatments and insights from recent clinical trials, highlighting significant advancements in chronic hand eczema and atopic dermatitis care presented at the EADV 2024.

Eczema 74